Klaus Maskos

Title: Klaus Maskos: Innovator in Tumor Necrosis Factor Research

Introduction

Klaus Maskos is a notable inventor based in Holzkirchen, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of tumor necrosis factor-alpha converting enzyme (TACE). His innovative work has led to advancements in understanding and manipulating this enzyme for therapeutic purposes.

Latest Patents

Klaus Maskos holds a patent for a "Crystalline TNF-α-converting enzyme and uses thereof." This patent describes a process for producing, purifying, and crystallizing TACE. The three-dimensional coordinates of the crystal are obtained through X-ray diffraction. These coordinates can be recorded on a computer-readable medium or stored in video memory, facilitating the study of TACE. Additionally, the coordinates are instrumental in designing, screening, and developing compounds that interact with TACE.

Career Highlights

Throughout his career, Klaus Maskos has worked with prominent organizations, including Immunex Corporation and the Max Planck Institute for Biochemistry. His research has been pivotal in advancing the understanding of TACE and its implications in various medical applications.

Collaborations

Klaus has collaborated with esteemed colleagues such as Roy A. Black and Raymond J. Paxton. Their combined expertise has contributed to the successful development of innovative solutions in the field of biochemistry.

Conclusion

Klaus Maskos is a distinguished inventor whose work on TACE has opened new avenues for research and therapeutic development. His contributions continue to impact the scientific community and enhance our understanding of critical biochemical processes.